EU remains Korea's top drug market

The European Union (EU) is emerging as the largest export market for Korean pharmaceuticals in the years ahead amid declining sales in the South Asian market due to the won's strength, an industry sources said recently.

Dong-A Pharm and Hanmi Pharm both are now rushing to make an inroad to the European market to expand its presence through the ongoing licensing-out negotiations, as the...